Board member Peter Slavin to exit American Well (AMWL) after 9+ years
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
American Well Corporation reports that board member Dr. Peter Slavin has notified the company he will resign from its Board of Directors, effective at the company’s next annual meeting of stockholders in 2026. He will continue to serve as a director until that meeting.
The company states that Dr. Slavin’s decision is due to his transition to a new role on the West Coast of the United States and is not the result of any disagreement regarding American Well’s operations, policies, or procedures. The company expresses appreciation for his more than nine years of board service.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Terms
Emerging growth company, Board of Directors, annual meeting of stockholders, Item 5.02
4 terms
Emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors or Certain Officers"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Board of Directors financial
"he will resign from the Board of Directors, effective on the date"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
annual meeting of stockholders financial
"effective on the date of the Company’s next annual meeting of stockholders"
Item 5.02 regulatory
"Item 5.02 Departure of Directors or Certain Officers; Election of Directors"
FAQ
Why is American Well (AMWL) director Dr. Peter Slavin resigning?
Dr. Peter Slavin is resigning from American Well’s Board because he is transitioning to a new role on the West Coast. The company states his decision is not due to any disagreement over operations, policies, or procedures.
When will Dr. Peter Slavin’s resignation from American Well (AMWL) take effect?
His resignation will be effective at American Well’s next annual meeting of stockholders in 2026. Until that meeting occurs, he will continue to serve as a member of the Board of Directors.
Does Dr. Slavin’s resignation signal a dispute with American Well (AMWL)?
The company explicitly states Dr. Slavin’s resignation is not due to any disagreement with American Well. It clarifies there are no disputes regarding operations, corporate policies, or procedures behind his decision to leave the Board.
How long has Dr. Peter Slavin served on American Well’s (AMWL) Board?
American Well notes that Dr. Slavin has served on its Board of Directors for more than nine years. The company publicly thanks him for this extended period of service and his contributions to the organization.
What form did American Well (AMWL) use to disclose Dr. Slavin’s resignation?
American Well disclosed Dr. Slavin’s planned resignation in a Form 8-K. The filing falls under Item 5.02, which covers departures and appointments of directors or certain executive officers and related compensatory arrangements.